FDA approval for Mounjaro cardiovascular risk reduction in type 2 diabetes
Eli Lilly’s Mounjaro has received FDA approval to cut cardiovascular risk in type 2 diabetes.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.